Page last updated: 2024-08-17

lysine and ganciclovir

lysine has been researched along with ganciclovir in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Jiang, Z; Li, Y; Liu, X; Liu, Y; Ma, X; Shen, Y; Wan, Q; Wu, W; Zhang, D	1

Other Studies

2 other study(ies) available for lysine and ganciclovir

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Connexin 43 SUMOylation improves gap junction functions between liver cancer stem cells and enhances their sensitivity to HSVtk/GCV. International journal of oncology, 2018, Volume: 52, Issue:3 Topics: Animals; Antiviral Agents; Cell Communication; Cell Line, Tumor; Combined Modality Therapy; Connexin 43; Female; Ganciclovir; Gap Junctions; Gene Expression Regulation, Neoplastic; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Herpesvirus 1, Human; Humans; Liver; Liver Neoplasms; Lysine; Male; Mice; Mice, Nude; Middle Aged; Neoplastic Stem Cells; Phosphotransferases (Alcohol Group Acceptor); SUMO-1 Protein; Sumoylation; Thymidine Kinase; Transfection; Treatment Outcome; Viral Proteins; Xenograft Model Antitumor Assays	2018

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

Connexin 43 SUMOylation improves gap junction functions between liver cancer stem cells and enhances their sensitivity to HSVtk/GCV.

International journal of oncology, 2018, Volume: 52, Issue:3

Topics: Animals; Antiviral Agents; Cell Communication; Cell Line, Tumor; Combined Modality Therapy; Connexin 43; Female; Ganciclovir; Gap Junctions; Gene Expression Regulation, Neoplastic; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Herpesvirus 1, Human; Humans; Liver; Liver Neoplasms; Lysine; Male; Mice; Mice, Nude; Middle Aged; Neoplastic Stem Cells; Phosphotransferases (Alcohol Group Acceptor); SUMO-1 Protein; Sumoylation; Thymidine Kinase; Transfection; Treatment Outcome; Viral Proteins; Xenograft Model Antitumor Assays

2018